JUL 11, 2019 9:12 PM PDT

High Risk: Seizures and Coma Linked to Use of Synthetic Cannabinoids in Adolescents

WRITTEN BY: C Reardon

A recent study by the American Academy of Pediatrics states that exposure to acute synthetic cannabinoid toxicity is far more dangerous to the adolescent brain than traditional cannabis toxicity and is linked to higher odds of neuropsychiatric morbidity.

Since 2011, poisonings related to synthetic cannabinoids have increased significantly. The total number of patients across all age groups who have sought out emergency medical treatment for synthetic cannabinoid toxicity is 30 times that of cannabis-related visits.

Synthetic cannabinoids are human-made chemicals similar to the chemicals found in the marijuana plant. Synthetic cannabinoids are sometimes called "synthetic marijuana" and are often said to be safe and legal alternatives to cannabis. The reality is, they may be far more harmful to the human brain than the natural plant. 

Dr. Sarah Ann R. Anderson-Burnett from Columbia University Herbert and Florence Irving Medical Center, New York City says that "adolescent use of synthetic cannabinoids can lead to severe outcomes, such as coma, seizures, and severe agitation."

Using data from the Toxicology Investigators Consortium Case Registry, Dr. Anderson-Burnett and colleagues investigated the effects of both on the brain.  

Their study included 107 adolescents with only synthetic cannabinoid exposure, 38 with synthetic cannabinoid polydrug exposure, 86 with only cannabis exposure, and 117 with cannabis polydrug exposure.

They found that those with synthetic cannabis exposure had 3.89-fold increased odds of seizures and 3.42-fold enhanced odds of coma or central nervous system depression.

Those with synthetic cannabinoid polydrug exposure had 4.8-fold higher odds of seizures than the cannabis polydrug group.

Photo Source: Pixabay.com

'Physicians should be aware of these neurological effects and should send their adolescent patients for screening for synthetic cannabinoids." Dr. Aviv Weinstein from Ariel University in the Israeli settlement of Ariel in the West Bank. "There is a lack of public awareness of the dangers of synthetic cannabinoids; this evidence should be disseminated to help (prevent use) of SCs among adolescents."
 

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
OCT 01, 2020
Health & Medicine
Menopausal Women Find Relief in Cannabis
OCT 01, 2020
Menopausal Women Find Relief in Cannabis
A growing number of women may be using cannabis for managing menopause symptoms, evidence from  the Midlife Women V ...
OCT 06, 2020
Clinical & Molecular DX
A Smart Tattoo That Could Save Your Life
OCT 06, 2020
A Smart Tattoo That Could Save Your Life
Color-changing tattoos, powered by nanotechnology, that sense imbalances in your biochemistry providing a visual signal ...
OCT 13, 2020
Cardiology
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
OCT 13, 2020
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
Biomarkers have taken the diagnostic field by storm over the past decade. The search for stable, easy to access indicato ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
OCT 15, 2020
Genetics & Genomics
Gene Variants Influence Aging and Mobility in the Elderly
OCT 15, 2020
Gene Variants Influence Aging and Mobility in the Elderly
Small changes in a gene that is involved in controlling the levels of the neurotransmitter dopamine could influence how ...
OCT 21, 2020
Microbiology
The First Treatment for Ebola is Approved by FDA
OCT 21, 2020
The First Treatment for Ebola is Approved by FDA
Ebola virus can pass from animals to humans, and between people. Rarely, it causes outbreaks but when it does, they can ...
Loading Comments...